| John Hillenkamp, | |
|
5629 Hwy 21 S, Rincon, GA 31326-9416 | |
| (912) 295-2133 | |
| (912) 295-5924 |
| Full Name | John Hillenkamp |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 7 Years |
| Location | 5629 Hwy 21 S, Rincon, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487187597 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 84403 (Georgia) | Primary |
| 390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Candler Hospital | Savannah, GA | Hospital |
| St Joseph's Hospital - Savannah | Savannah, GA | Hospital |
| East Georgia Regional Medical Center | Statesboro, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Georgia Emergency Associates | 1052216389 | 6 |
News Archive
On Oct. 11, 2011, the FDA approved a labeling supplement for EUFLEXXA (1% sodium hyaluronate) that provides 26-week efficacy data from the FLEXX trial, as well as, 52-week safety data to demonstrate the safety of repeated injection cycles.
Why do other countries spend less on health care and yet achieve near-universal coverage and often better outcomes than the United States? This question has come up repeatedly during the health reform debate, and yet the answers still aren't clear. How much of a factor is the health care system? Population differences? These are some of the questions addressed in Health Care in World Cities, a new book co-authored by Hastings Center scholar Michael Gusmano and published by Johns Hopkins University Press.
In a University of Michigan Health System study, 1 out of 3 patients with chronic pain reported using complementary and alternative medicine therapies such as acupuncture and chiropractic visits for pain relief.
The world could be on its way towards eliminating tuberculosis (TB) if governments and donors fully invest in a plan released today by the Stop TB Partnership. The global plan to stop TB 2011-2015: transforming the fight towards elimination of tuberculosis for the first time identifies all the research gaps that need to be filled to bring rapid TB tests, faster treatment regimens and a fully effective vaccine to market.
Ardea Biosciences, Inc., a biotechnology company focused on the development of small-molecule therapeutics for the treatment of serious diseases, reported recent accomplishments and financial results for the second quarter and six months ended June 30, 2010.
› Verified 8 days ago
| Entity Name | Georgia Emergency Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528098290 PECOS PAC ID: 1052216389 Enrollment ID: O20031201000427 |
News Archive
On Oct. 11, 2011, the FDA approved a labeling supplement for EUFLEXXA (1% sodium hyaluronate) that provides 26-week efficacy data from the FLEXX trial, as well as, 52-week safety data to demonstrate the safety of repeated injection cycles.
Why do other countries spend less on health care and yet achieve near-universal coverage and often better outcomes than the United States? This question has come up repeatedly during the health reform debate, and yet the answers still aren't clear. How much of a factor is the health care system? Population differences? These are some of the questions addressed in Health Care in World Cities, a new book co-authored by Hastings Center scholar Michael Gusmano and published by Johns Hopkins University Press.
In a University of Michigan Health System study, 1 out of 3 patients with chronic pain reported using complementary and alternative medicine therapies such as acupuncture and chiropractic visits for pain relief.
The world could be on its way towards eliminating tuberculosis (TB) if governments and donors fully invest in a plan released today by the Stop TB Partnership. The global plan to stop TB 2011-2015: transforming the fight towards elimination of tuberculosis for the first time identifies all the research gaps that need to be filled to bring rapid TB tests, faster treatment regimens and a fully effective vaccine to market.
Ardea Biosciences, Inc., a biotechnology company focused on the development of small-molecule therapeutics for the treatment of serious diseases, reported recent accomplishments and financial results for the second quarter and six months ended June 30, 2010.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John Hillenkamp, 5629 Hwy 21 S, Rincon, GA 31326-9416 Ph: (912) 295-2133 | John Hillenkamp, 5629 Hwy 21 S, Rincon, GA 31326-9416 Ph: (912) 295-2133 |
News Archive
On Oct. 11, 2011, the FDA approved a labeling supplement for EUFLEXXA (1% sodium hyaluronate) that provides 26-week efficacy data from the FLEXX trial, as well as, 52-week safety data to demonstrate the safety of repeated injection cycles.
Why do other countries spend less on health care and yet achieve near-universal coverage and often better outcomes than the United States? This question has come up repeatedly during the health reform debate, and yet the answers still aren't clear. How much of a factor is the health care system? Population differences? These are some of the questions addressed in Health Care in World Cities, a new book co-authored by Hastings Center scholar Michael Gusmano and published by Johns Hopkins University Press.
In a University of Michigan Health System study, 1 out of 3 patients with chronic pain reported using complementary and alternative medicine therapies such as acupuncture and chiropractic visits for pain relief.
The world could be on its way towards eliminating tuberculosis (TB) if governments and donors fully invest in a plan released today by the Stop TB Partnership. The global plan to stop TB 2011-2015: transforming the fight towards elimination of tuberculosis for the first time identifies all the research gaps that need to be filled to bring rapid TB tests, faster treatment regimens and a fully effective vaccine to market.
Ardea Biosciences, Inc., a biotechnology company focused on the development of small-molecule therapeutics for the treatment of serious diseases, reported recent accomplishments and financial results for the second quarter and six months ended June 30, 2010.
› Verified 8 days ago
Dr. Thomas Reagan Wolf, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 5629 Hwy 21 S, Rincon, GA 31326 Phone: 912-295-2133 Fax: 912-295-5924 | |
Megan D Hershey, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 5629 Hwy 21 S, Rincon, GA 31326 Phone: 912-295-2133 | |
James R Gill, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 5629 Hwy 21 South, Rincon, GA 31326 Phone: 912-295-2133 Fax: 912-295-5924 | |
Andrew R Tee Vi, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 5629 Hwy 21 South, Rincon, GA 31326 Phone: 912-295-2133 Fax: 912-295-5924 | |
David Stephen Wong, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 5629 Hwy 21 S, Rincon, GA 31326 Phone: 912-295-2133 Fax: 912-295-5924 | |
Christopher Daniel Kohls, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 5629 Hwy 21 South, Rincon, GA 31326 Phone: 912-295-2133 Fax: 912-295-5924 | |
Carl Victor Hurtig, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 5629 Hwy 21 South, Rincon, GA 31326 Phone: 912-295-2133 Fax: 912-295-5924 |